Enhanced binding of advanced glycation endproducts (AGE) by the ApoE4 isoform links the mechanism of plaque deposition in Alzheimer's disease
Section snippets
Acknowledgements
The authors thank Dr. Michael Yamin for critical comments and Dr. Richard Bucala for providing anti-AGE antibody. This study is partially supported by awards from American Diabetes Association and Institute for Advanced Studies in Immunology and Aging to Y.M.L.
References (17)
- et al.
Glycation and microglial reaction in lesions of Alzheimer's disease
Neurobiol. Aging
(1996) - et al.
Isoform-specific interactions of apolipoprotein e with the microtubule-associated protein MAP2c: implications for Alzheimer's disease
Neurosci. Lett.
(1994) - et al.
Analysis of microtubule-associated protein tau glycation in paired helical filaments
J. Biol. Chem.
(1994) - et al.
Advanced glycation endproducts-associated parameters in the peripheral blood of patients with Alzheimer's disease
Life. Sci.
(1996) - et al.
Alzheimer's disease, risky apolipoprotein in brain
Nature
(1994) - et al.
Tau protein from Alzheimer's disease patients is glycated at its tubulin-binding domain
J. Neurochem.
(1995) - et al.
Macrophages synthesize and secrete a 25-kilodalton protein that binds insulin-like growth factor-I
J. Immunol.
(1996) - et al.
Prevention of cardiovascular and renal pathology of aging by the advanced glycation inhibitor aminoguanidine
Proc. Natl. Acad. Sci. USA
(1996)
Cited by (64)
Impact of micronutrients and nutraceuticals on cognitive function and performance in Alzheimer's disease
2024, Ageing Research ReviewsPrecision Nutrition in Aging and Brain Health
2023, Precision Nutrition: the Science and Promise of Personalized Nutrition and HealthThe ketogenic diet as a potential treatment and prevention strategy for Alzheimer's disease
2019, NutritionCitation Excerpt :The link between diabetes and AD, for example, could be due to insulin resistance and spikes in blood sugar increasing the glycation of ApoE proteins. Furthermore, ApoE proteins transcribed and translated from the E4 variant of the gene are three times as AGE-binding than those of other ApoE gene variants [22]. This suggests that ApoE4(+) individuals might be more susceptible to the cascade effect proposed by Seneff et al. [20], which may explain why they are more at risk for developing AD.
G82S polymorphism of receptor for advanced glycation end products gene and serum soluble RAGE levels in mild cognitive impairment and dementia of Alzheimer's type patients in Turkish population
2019, Journal of Clinical NeuroscienceCitation Excerpt :One major mechanism is the Aβ deposition and the neuroinflammation it triggers. Enhanced binding of advanced glycation endproducts (AGE) by the APOE-ɛ4 isoform is a step in the mechanism of plaque deposition in AD [8]. AGEs are formed by a non enzymatic reaction of sugars with protein deposits.
Effects of glycation on human γD-crystallin proteins by different glycation-inducing agents
2018, International Journal of Biological MacromoleculesCitation Excerpt :On the molecular level, conformational changes of the lens' proteins (e.g., secondary or tertiary structure changes) lead to the cross-linking, aggregation, and insolubilization of these proteins, causing a browning and yellowing in lens color. Galactose, a carbohydrate that is normally present in the body in the form of a reducing sugar, has been found to react readily with proteins and peptides both in vitro and in vivo to form AGEs; this process is highly correlated to age-associated pathologies that include diabetes and Alzheimer's disease [59–62]. It has also been implicated in galactosemia, a rare hereditary disease, due to the lack of enzymes that metabolize galactose in the body, which leads to the development of congenital cataract secondary to the accumulation of galactitol in the crystalline lens [63].
The Influences of Dietary Sugar and Related Metabolic Disorders on Cognitive Aging and Dementia
2016, Molecular Basis of Nutrition and Aging: A Volume in the Molecular Nutrition Series